Incysus Therapeutics
BioTech/Drugs - New York, NY, US
Incysus Therapeutics Employees
Incysus Therapeutics Senior Management
Incysus Therapeutics Details
IN8bio Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies for the treatment of cancer. Gamma-delta T cells are naturally occurring immune cells that embody properties of both the innate and adaptive immune systems, and can intrinsically differentiate between healthy and diseased tissue. IN8bio develops ex vivo-expanded and activated gamma-delta T cell based upon its deep expertise in gamma-delta T cell biology, proprietary genetic engineering and cell-type specific manufacturing capabilities, which we refer to collectively as our DeltEx platform. IN8bio's platform employs allogeneic, autologous and genetically modified approaches to develop novel cell therapies, which are designed to effectively identify and eradicate tumor cells. IN8bio is currently the most clinically advanced gamma-delta T cell company and the first company to bring genetically modified gamma-delta T cells into the clinic.For more information about the Company and its programs, visit www.IN8bio.com.
Incysus Therapeutics Technologies
Email Providers
Gmail
CMS
WP Engine
Other
Google Apps
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud
Analytics and Tracking
Google Analytics